Skip to main content
. 2020 Sep 30;42(5):1995–2003. doi: 10.1007/s10072-020-04726-6

Fig. 1.

Fig. 1

ARR before and after fingolimod therapy in the whole REALMS population and according to previous disease-modifying therapies. Error bars represent 95% CIs. See text for p values of comparisons not marked with ns